Susan Sweeney

SUSAN SWEENEY is newly appointed as the CEO operations lead at Bristol-Myers Squibb.  In this role she collaborates with the CEO, leadership team and direct reports to advance organizational priorities and execute company strategy. During her tenure with BMS, Sweeney has held a variety of positions covering multiple therapeutic areas and leadership roles in global commercialization and U.S. pharmaceuticals. Most recently, she served as U.S. vice president, cardiovascular franchise, where she led the successful, continued growth of Eliquis. Previously, she successfully led a number of marketing teams as vice president, marketing diabetes franchise, vice president, U.S. Plavix and Avapro/Avalide marketing; executive director, U.S. Orencia marketing and senior director, Apixaban global marketing. She also served as senior director, global marketing for Plavix. Earlier in her tenure, Sweeney served as the global marketing lead for the Orencia launch, director of Edifoligide and Tequin and senior manager for Abilify and managed healthcare. Sweeney earned a B.A. from Gettysburg College and an M.P.H. from Columbia University Mailman School of Public Health. @bmsnews